NVLPF (Nova Leap Health) Return-on-Tangible-Asset: 22.01% (As of Mar. 2026)


NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.25
GF Value $0.18
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nova Leap Health Return-on-Tangible-Asset?

Nova Leap Health NVLPF 50 Return-on-Tangible-Asset is 22.01% as of Mar. 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Nova Leap Health ranks better than 55.51% on this metric.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Nova Leap Health's annualized Net Income for the quarter that ended in Mar. 2026 was $1.30 Mil. Nova Leap Health's average total tangible assets for the quarter that ended in Mar. 2026 was $5.91 Mil. Therefore, Nova Leap Health's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 22.01%.

The historical rank and industry rank for Nova Leap Health's Return-on-Tangible-Asset or its related term are showing as below:

NVLPF' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -238.69   Med: -14.18   Max: 25.16
Current: 3.7

During the past 10 years, Nova Leap Health's highest Return-on-Tangible-Asset was 25.16%. The lowest was -238.69%. And the median was -14.18%.

NVLPF's Return-on-Tangible-Asset is ranked better than
55.51% of 681 companies
in the Healthcare Providers & Services industry
Industry Median: 2.43 vs NVLPF: 3.70

Nova Leap Health  (OTCPK:NVLPF) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Nova Leap Health Return-on-Tangible-Asset Related Terms


Nova Leap Health Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health Return-on-Tangible-Asset Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.17 -11.30 -16.81 23.94 -3.26

Nova Leap Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.45 -33.94 29.23 -3.66 22.01

NVLPF vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health Return-on-Tangible-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's Return-on-Tangible-Asset falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health Return-on-Tangible-Asset Calculation

Nova Leap Health's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-0.19/( (5.781+5.873)/ 2 )
=-0.19/5.827
=-3.26 %

Nova Leap Health's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1.3/( (5.873+5.941)/ 2 )
=1.3/5.907
=22.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data.

What does a Return-on-Tangible-Asset of 22.01% mean?
Nova Leap Health (NVLPF) has a Return-on-Tangible-Asset of 22.01% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #303 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 44.5%.
Is Nova Leap Health's Return-on-Tangible-Asset too high?
Nova Leap Health's current Return-on-Tangible-Asset is 22.01%. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Nova Leap Health's value of 22.01% is 805.8% above this industry median. Based on the distribution chart, Nova Leap Health ranks #303 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #303 out of 681 companies for Return-on-Tangible-Asset. This puts Nova Leap Health in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Nova Leap Health's value of 22.01% is 805.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Return-on-Tangible-Asset of 22.01% is 805.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Return-on-Tangible-Asset is 22.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.18, compared to a current price of $0.25 — trading 36.9% above its estimated fair value. The current Return-on-Tangible-Asset is 22.01% and 805.8% above the Healthcare Providers & Services industry median of 2.43. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Return-on-Tangible-Asset is 22.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.25 is trading 36.9% above its estimated GF Value™ of $0.18. GuruFocus considers Nova Leap Health to be Fairly Valued.

Key valuation signals for NVLPF:

  • Return-on-Tangible-Asset: 22.01%
  • GF Value™: $0.18 vs. price of $0.25 (36.9% above fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 805.8% above the Healthcare Providers & Services median (#303 of 681)

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$0.18
GF Value